The department treats about 300 patients with growth hormones. This includes patients with a congenital growth hormone deficiency and patients with growth hormone deficiency caused by radiation of the brain or brain tumour surgery.
In addition, growth hormone treatment has been approved for a number of other patient categories, such as girls with Turner syndrome, short children born SGA (Small for Gestational Age), children who are short due to a chronic kidney disease and children with Prader-Willis syndrome.
On the research part, we focus on IGF-I, IGF-I binding proteins and the importance of growth hormone receptor polymorphisms for pre- and postnatal growth patterns.
Head of Department, Professor Anders Juul is the initiator and main coordinator of the North-European Multicenter Study of Growth Hormone Treatment in SGA children.